Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;236(7):5362-5372.
doi: 10.1002/jcp.30234. Epub 2020 Dec 23.

LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production

Heba Nafea  1 , Rana A Youness  2 , Khaled Abou-Aisha  3 , Mohamed Z Gad  1
Affiliations

LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production

Heba Nafea et al. J Cell Physiol. 2021 Jul.

Abstract

This study aimed to unravel the regulatory role of noncoding RNAs (ncRNA) on the nitric oxide (NO) machinery system in triple-negative breast cancer (TNBC) patients and to further assess the influence of NO-modulating ncRNAs on TNBC progression, immunogenic profile, and the tumor microenvironment (TME). The results revealed miR-939-5p and lncRNA HEIH as novel ncRNAs modulating NO machinery in TNBC. MiR-939-5p, an underexpressed microRNA (miRNA) in BC patients, showed an inhibitory effect on NOS2 and NOS3 transcript levels on TNBC cells. In contrast, HEIH was found to be markedly upregulated in TNBC patients and showed a modulatory role on miR-939-5p/NOS2/NO axis. Functionally, miR-939-5p was characterized as a tumor suppressor miRNA while HEIH was categorized as a novel oncogenic lncRNA in TNBC. Finally, knocking down of HEIH resulted in improvement of immunogenic profile of TNBC cells through inducing MICA/B and suppressing the immune checkpoint inhibitor PDL1. In the same context, knockdown of HEIH resulted in the alleviation of the immune-suppressive TME by repressing interleukin-10 and tumor necrosis factor-α levels. In conclusion, this study identifies miR-939-5p as a tumor suppressor miRNA while HEIH as an oncogenic lncRNA exhibiting its effect through miR-939-5p/NOS2/NO axis. Therefore, repressing BC hallmarks, improving TNBC immunogenic profile, and trimming TME.

Keywords: MICA; MICB; MiR-939-5p; NOS2; lncRNA HEIH; triple negative breast cancer.

PubMed Disclaimer

References

REFERENCES

    1. Abdel-Latif, M., & Youness, R. A. (2020). Why natural killer cells in triple negative breast cancer? World Journal of Clinical Oncology, 11(7), 464-476. https://doi.org/10.5306/wjco.v11.i7.464
    1. Aboelenein, H. R., Hamza, M. T., Marzouk, H., Youness, R. A., Rahmoon, M., Salah, S., & Abdelaziz, A. I. (2017). Reduction of CD19 autoimmunity marker on B cells of paediatric SLE patients through repressing PU.1/TNF-alpha/BAFF axis pathway by miR-155. Growth Factors, 35(2-3), 49-60. https://doi.org/10.1080/08977194.2017.1345900
    1. Ahmed Youness, R., Amr Assal, R., Mohamed Ezzat, S., Zakaria Gad, M., & Abdel Motaal, A. (2020). A methoxylated quercetin glycoside harnesses HCC tumor progression in a TP53/miR-15/miR-16 dependent manner. Natural Product Research, 34(10), 1475-1480. https://doi.org/10.1080/14786419.2018.1509326
    1. Awad, A. R., Youness, R. A., Ibrahim, M., Motaal, A. A., El-Askary, H. I., Assal, R. A., & Gad, M. Z. (2019). An acetylated derivative of vitexin halts MDA-MB-231 cellular progression and improves its immunogenic profile through tuning miR-20a-MICA/B axis [published online ahead of print November 6, 2019]. Natural Product Research, 1-5. https://doi.org/10.1080/14786419.2019.1686372
    1. Basudhar, D., Glynn, S. A., Greer, M., Somasundaram, V., No, J. H., Scheiblin, D. A., Garrido, P., Heinz, W. F., Ryan, A. E., Weiss, J. M., Cheng, R. Y. S., Ridnour, L. A., Lockett, S. J., McVicar, D. W., Ambs, S., & Wink, D. A. (2017). Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer. Proceedings of the National Academy of Sciences of the United States of America, 114(49), 13030-13035. https://doi.org/10.1073/pnas.1709119114

Publication types

MeSH terms

LinkOut - more resources